tradingkey.logo
tradingkey.logo
Search

MannKind Corp

MNKD
Add to Watchlist
4.520USD
+0.470+11.60%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.40BMarket Cap
LossP/E TTM

TradingKey Stock Score of MannKind Corp

Currency: USD Updated: 2026-07-02

Key Insights

MannKind Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 34 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.59.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

MannKind Corp's Score

Industry at a Glance

Industry Ranking
34 / 387
Overall Ranking
108 / 4565
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

MannKind Corp Highlights

StrengthsRisks
MannKind Corporation is a biopharmaceutical company engaged in transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. Its commercial assets include Afrezza, FUROSCIX and V-Go along with Tyvaso DPI. Its commercializing Afrezza (insulin human) Inhalation Powder, an ultra-rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin. Its orphan lung disease product, Tyvaso DPI (treprostinil) inhalation powder, is used in the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 75.39% year-on-year.
Undervalued
The company’s latest PE is -57.88, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 207.84M shares, increasing 10.46% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 108.23K shares of this stock.

Analyst Rating

Based on 8 analysts
Buy
Current Rating
7.594
Target Price
+87.50%
Upside Space

FAQs

How does TradingKey generate the Stock Score of MannKind Corp?

The TradingKey Stock Score provides a comprehensive assessment of MannKind Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of MannKind Corp’s performance and outlook.

How do we generate the financial health score of MannKind Corp?

To generate the financial health score of MannKind Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects MannKind Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of MannKind Corp.

How do we generate the company valuation score of MannKind Corp?

To generate the company valuation score of MannKind Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare MannKind Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of MannKind Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of MannKind Corp.

How do we generate the earnings forecast score of MannKind Corp?

To calculate the earnings forecast score of MannKind Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on MannKind Corp’s future.

How do we generate the price momentum score of MannKind Corp?

When generating the price momentum score for MannKind Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of MannKind Corp’s prices. A higher score indicates a more stable short-term price trend for MannKind Corp.

How do we generate the institutional confidence score of MannKind Corp?

To generate the institutional confidence score of MannKind Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about MannKind Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of MannKind Corp.

How do we generate the risk management score of MannKind Corp?

To assess the risk management score of MannKind Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of MannKind Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of MannKind Corp.